A detailed history of Optiver Holding B.V. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 321 shares of ARDX stock, worth $1,617. This represents 0.0% of its overall portfolio holdings.

Number of Shares
321
Previous 297 8.08%
Holding current value
$1,617
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$4.49 - $6.85 $107 - $164
24 Added 8.08%
321 $1,000
Q3 2024

Nov 14, 2024

SELL
$5.28 - $7.57 $11,156 - $15,995
-2,113 Reduced 87.68%
297 $2,000
Q2 2024

Aug 14, 2024

BUY
$5.89 - $9.31 $14,194 - $22,437
2,410 New
2,410 $17,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $779M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Optiver Holding B.V. Portfolio

Follow Optiver Holding B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.